Nokia

Real-time clinical networks at scale

Issy-les-Moulineaux, France

Nokia acquired French digital health company Withings in 2016 for $192 million, rebranding its products. After struggling, the digital health business was sold back to Withings' co-founder in 2018. Nokia now focuses on providing intelligent infrastructure and digital technologies to healthcare organizations, leveraging technologies like 5G-Advanced and 6G.

Shareable draft

Check out Nokia on @MedStartr Today Nokia acquired French digital health company Withings in 2016 for $192 million, rebranding its products. After struggling, the digital health business was sold back to Withings' co-founder in 2018. Nokia now focuses on providing intelligent infrastructure and digital technologies to healthcare organizations, leveraging technologies like 5G-Advanced and 6G. #Diabetes #Hypertension #ChronicHeartFailure #ElderlyCare #ObesityOverweight #HealthcareInfrastructure #MedMo #MedStartrVentures

https://www.medstartr.ai/s/kLGkJVLQAdM

Note, this image was autogenerated by Syggy based on what we know about the company. It is not an official company publication.

Get Involved in Nokia

How We Help

Problem Statement

Lack of accurate and consistent patient-generated health data for both consumer self-monitoring and remote patient tracking by physicians.

Core Technology

5G-Advanced; 6G; intelligent infrastructure; private network solutions; AI for diagnostics

Key Differentiators

Accurate collection of patient-generated health data, remote patient tracking capabilities, comprehensive product portfolio, and dedicated B2B solutions for healthcare providers and researchers.

Clinical Focus

Obesity, diabetes, hypertension, chronic heart failure, elderly care, and support for decentralized clinical trials.

Target Customers

Consumers, healthcare providers, and researchers.

Product Stage

Mature

Company Info

Business Model: B2C, B2B, Subscription
Founded: 2008
Total Funding: Only accessible to MedStartr community members. Join now
Only accessible to MedStartr community members.
Join now
Website: www.withings.com

Disease Areas

Diabetes Hypertension Chronic Heart Failure Elderly Care Obesity & Overweight

Technologies

Connected Health DevicesSmart ScalesBlood Pressure MonitorsSmartwatchesSleep SystemsThermometersCardiac Monitoring & ECGAI & Machine Learning

Clinical & IP

🔬

Clinical Validation

Devices are utilized for real-world data collection in decentralized clinical trials.

🌐Website

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of Nokia?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.